Symlin · Amylin Analog
Amylin analog — glucose control and satiety.
FDA
Approved
WADA
Not Listed
HALF-LIFE
~48 minutes
ROUTE
SubQ injection (before meals)
SCHEDULE
3× daily (before meals)
In Plain English
Amylin analog — glucose control and satiety.
Status & Legality
What do these mean?Blood sugar control
Satiety enhancement
Weight management
Diabetes adjunct
Pramlintide is a synthetic analog of amylin, a peptide co-secreted with insulin from pancreatic beta cells. It slows gastric emptying, reduces post-meal glucagon secretion, and induces satiety — resulting in lower post-meal blood sugar spikes and reduced caloric intake. FDA-approved as an adjunct to insulin.
Nausea (most common)
Hypoglycemia (if insulin not reduced)
Vomiting
Anorexia
Mixing pramlintide and insulin in the same syringe — they are physically incompatible and will clump
Not reducing mealtime insulin by 50% when starting — severe hypoglycemia is the most dangerous side effect
Using it for weight loss without insulin-dependent diabetes — semaglutide is more effective and simpler for pure appetite suppression
Insulin — critical to reduce mealtime insulin dose by 50% when initiating; hypoglycemia risk is significant
Sulfonylureas — additive hypoglycemia risk; monitor blood glucose closely
Oral medications — slowed gastric emptying delays absorption and peak blood levels of all oral drugs
Pramlintide is most valuable for insulin-dependent diabetics struggling with post-meal spikes despite adequate insulin dosing. It works differently from GLP-1s — through amylin receptors, not GLP-1 receptors — meaning it adds a distinct mechanism. For non-diabetics seeking appetite control, semaglutide is significantly more effective and simpler to use.
SEMAGLUTIDE
FDA-approved GLP-1 agonist — weight loss and blood sugar control.
TIRZEPATIDE
Dual GIP/GLP-1 agonist — superior weight loss to semaglutide.
LIRAGLUTIDE
Daily GLP-1 agonist — the original injectable for weight loss.
Free, no account needed
Drop your email and we'll send the one-page starter checklist beginners actually need first. No account needed.
No spam, and we never sell your email. Just the checklist. Email support@pepvault.us to opt out any time.
Stats
Sources & Studies
Ratner RE. et al., Diabet Med, 2004